Nelly

Overview
News
Hospital Management?
Product stageSegments
Go-to-Market
?
Clinical documentation improvement solutions
?

Nelly is a German healthtech company providing a digital solution for streamlining patient admission, invoicing, and payment processes in medical practices. Launched in 2021, Nelly's platform seamlessly integrates with existing practice management software, offering a user-friendly approach to digitalize medical administration work. Through Nelly's technology, the entire patient visit, from registration and medical history to document signing and payment, can be efficiently handled using patients' smartphones, eliminating communication disruptions. Nelly's platform ensures secure and GDPR-compliant handling of patient data, with all information encrypted and stored on German servers.

A notable feature of Nelly's offering is its unique "factoring" and billing product, enabling medical invoices to be delivered digitally and paid with a single click. By digitizing administrative steps, Nelly's solution has the potential to reduce payment fees by 30% to 50%, minimizing expenses related to invoice creation, postage fees, and factoring costs. As of June 2023, Nelly had digitized over 3 million documents and invoices, empowering over 450 practices and benefiting more than 350,000 patients.

In June 2023, Nelly secured a EUR 15 million Series A funding round led by Lakestar, with participation from b2venture and Motive Ventures. This investment will support Nelly's growth in Germany, product development, enhancement of fintech capabilities, and expansion into new medical verticals and markets.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Spreeufer 3 Berlin DEU
Founded year:
2021
Employees:
11-50
IPO status:
Private
Total funding:
USD 20.6 mn
Last Funding:
USD 16.4 mn (Series A; Jun 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.